Answer
The most commonly reported adverse reactions to tezepelumab during asthma treatment are pharyngitis (4.1%) and arthralgia (3.8%).
Sources for this answer
- Tezspire 210 mg solution for injection in pre-filled syringeAstraZeneca UK Limited · emc · SmPC §4.8 Undesirable effects · Version 4Document updated
Sources checked